Has Bryan Daines received payments from drug or device companies?

Yes. Drug and device makers reported $8,857 in general payments to Bryan Daines across 181 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bryan Daines did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bryan Daines come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bryan Daines

Dermatology · Trenton, MINPI 1679212443

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.7% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations.

$8,857in general payments, 2019–2025

Across 181 payments — averaging $48.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Dermavant Sciences, Inc.$935
Regeneron Healthcare Solutions, Inc.$896
Sanofi$859
Johnson & Johnson$732
UCB, Inc.$716
plus $4K from 18 others

What the payments were for

Food & beverage$8,65798%
Education$2002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	28	$1,174
Dermavant Sciences, Inc.	18	$935
Regeneron Healthcare Solutions, Inc.	21	$896
Sanofi	21	$859
Johnson & Johnson	13	$732
UCB, Inc.	16	$716
Galderma Laboratories, L.p.	6	$418
Lilly USA, LLC	10	$375
LEO Pharma Inc.	5	$352
E.r. Squibb & Sons, L.L.C.	4	$338
Incyte Corporation	6	$327
Novartis	8	$292
Boehringer Ingelheim	4	$261
Arcutis Biotherapeutics, Inc.	2	$244
Sun Pharmaceutical Industries Inc.	2	$239
Pfizer	3	$169
Kerecis Limited	1	$139
Biofrontera Inc.	3	$133
Journey Medical Corporation	3	$60
Almirall LLC	2	$53
Organogenesis Inc.	1	$47
Kyowa Kirin, Inc.	2	$41
Janssen Scientific Affairs, LLC	1	$33
Mayne Pharma Commercial LLC	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,857 in reported general payments places this provider in the 80th percentile of 404 dermatology providers in Michigan.

See all dermatology providers in Michigan →

Other dermatology in Trenton

Arjun BalTrenton$11K
Linda Stein GoldWest Bloomfield$3.3M
Kristi HawleyCaledonia$2.2M
David AltmanWarren$1.9M
Michael SiegelWaterford$708K
Johann GudjonssonAnn Arbor$535K
Michael DormanWest Bloomfield$433K
Steven DaveluyDearborn$350K
Benjamin WorkmanMidland$284K
Diana WestgateKalamazoo$252K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →